Navigation Links
Low Abundance cDNA Cloned Using Stratagenes Human Universal ,,, cDNA Library

fying the correct complete cDNA sequence is often hindered by the short sequences of the reported ESTs that are biased towards the 5 end. Since the EST cDNA inserts are generally not full-length and the clones are not always available, there is still a need to screen libraries to isolate a full-length cDNA. However, conventional library screening is tedious and time consuming, especially for a low-abundance protein.

To circumvent these problems, we used Stratagenes HUCL arrays to isolate a full-length clone that encodes Apobec-1 Complementation Factor (ACF), a novel RNA-binding protein that is involved in the post-transcriptional editing of apolipoprotein B (apo-B) mRNA in mammals. The HUCL array is a collection of more than 145,000 primary clones in 1536 pools of 96 clones each, which are arranged on four master membranes. Because of the librarys large representation of high-quality cDNA clones, human genes can be quickly identified and subsequently isolated.

Purification of ACF

Editing apo-B mRNA involves a site-specific deamination reaction that converts cytidine6666 to uridine and generates a premature translational stop codon.2 Although the catalytic subunit of the editing enzyme was discovered in 1993, the identity of the RNA-binding subunit has been elusive, despite intensive efforts by several groups. We previously characterized and purified a 65-kDa protein from baboon kidney that had all the properties expected for the RNA-binding subunit. 3,4 The protein was purified over 140,000-fold, and silver staining of the final purified fraction showed the presence of a single protein of 65
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
2. Oil-Free PCR Using the Hot Top Assembly
3. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Using XL1-Red Mutator Strain to Generate Esterase Variants
6. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
7. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy

Post Your Comments:
(Date:12/2/2009)...2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.... ONCY ) announced today that in connection with it...ters have exercised in full their over-allotment o...ach unit is comprised of one common share and 0.4 ...t a price of US$3.00 per unit. Each whole common s...
(Date:12/2/2009)... Israel, December 2 Gamida Cell an...reclinical (animal study) safety and,efficacy of a...om Weill,Cornell Medical College and Gamida Cell. ...anemias such as Cooley,s Anemia. , Gamida...pand, ex vivo,populations of stem/progenitor cell...
(Date:12/2/2009)...PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NAS...iopharmaceutical company focused on endocrine ther...od and Drug Administration (FDA) has granted Fast ...ay inhibitor compound, perifosine (KRX-0401), for ...oma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( KE...
(Date:12/1/2009)...ry Solomon announced that he has joined Carolina E...website at www.DrKerrySolomon.com , which was dev...s a proven LASIK, lens implant, and cataract surge...or his substantial contributions to improving visi...LASIK Surgeons, which screens LASIK surgeons based...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...tockholders to Determine Fate of Company,s Remaini...ciNova, Inc. Offers Avigen Stockholders Extraordin...n. 9 Biotechnology Value Fund, L.P. together with...s requested that the Board of Directors of Avigen,...Meeting of the stockholders for the purpose of rep...
...all/ - Victhom Human Bionics Inc., "Victhom" (TSX:...d corporate Website at www.victhom.com . The Webs...ces in the Company,s two operating divisions; Neur...timulation device for gait disorders, and Biotroni...zed prostheses for above-knee amputees. , Commenti...
...g-Plough Corporation (NYSE: SGP ) will provide a... Koestler, Ph.D., executive vice president and pre... 27th Annual J.P. Morgan Healthcare Conference in ... 3:30 p.m. (PST) (6:30 p.m. EST). Koestler is exp... and select projects in development. , , A live a...
Other Biology Technology:Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 2Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 4Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 5Victhom Announces Launch of Enhanced Company Website 2
(Date:12/3/2009)... Rapids, Mich. (Dec. 3, 2009) Van Andel Researc...cisely how the plant hormone abscisic acid (ABA) w... to environmental stresses such as drought and col...re , could help engineer crops that thrive in hars...food shortages. The findings could also have impl...
(Date:12/3/2009)...you ever felt overly upset by a social snubbing? Y..., Scientists have long known that opium-like pain... pain, but also some forms of emotional stress. No... member Markus Heilig shows that small genetic dif...etermine the intensity of people,s responses to so...
(Date:12/3/2009)...nish researchers have measured CO2 levels for the ...ere) over a sparsely inhabited rural area near Val... kind in the Iberian Peninsula, show that the leve... Over recent years, physicists and meteorologists ...(CO2) levels, and how these have evolved in the tr...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 1Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 3Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 1Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 2Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 3Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 1Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 2Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 3Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 5Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 6Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 7Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 8Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 9Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 10Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 11Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 12Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 13Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 14Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 15Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 16Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 17Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 18Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 19Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 20Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 21
...kind of learning that allows humans to get used to...uman vital signs adapt to medical interventions su... Chi-Sang Poon, a research scientist at the Harvar...HST), suggests that this innate ability to adapt, ... to design more effective and less costly artifici...
...ologie Neurovg tative (CNRS-INRA-Universit Paul C ...que (INRA-Universit Paul Czanne) and from the D ...NSERM, Hopital Purpan Toulouse), and in particular..., Directeur de Recherche CNRS, Dr Franois Terc , C...confrence and Dr Caroline Fasano, author in 2004 o...
...blishers, will publish the Journal of Coastal Cons...UCC the Coastal Union. Linking science and polic...ournals in coastal science, the International Jour... The first issue of the relaunched JCCO, with a ne... orientation and new subtitle, will be published b...
Other Biology News:Rhythmic breathing adapts to external beat through 'brain calculus' 2Rhythmic breathing adapts to external beat through 'brain calculus' 3Springer will publish Journal of Coastal Conservation 2
...0 System revolutionizes DNA sequencing, delivering...he Genome Sequencer 20 System includes: Instrume...ibrary construction, amplification, and sequencing...ly The instrument is the centerpiece of the Gen...
Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
...gle Donor • Human serum is obtained from norm...test for Human Immunodeficiency Virus Antigen (s) ...rus (Anti-HIV 1/2), Hepatitis C Virus (HCV), and N... and Non-reactive by a screening test for syphilis...
Customized Profile from Novascreen-a Caliper Life Sciences Company
Biology Products: